# Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

> **NCT00264420** · PHASE1 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 4 (actual)

## Conditions studied

- Bone Metastases
- Breast Cancer
- Lung Cancer
- Prostate Cancer

## Interventions

- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00264420
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2010-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264420, "Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00264420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*